The products may help some people with the neurological disorder, but obtaining the right treatments can be difficult
The federal government has since legalized CBD, and it has become a multibillion-dollar industry. The Food and Drug Administration also has approved one cannabis-derived prescription drug, Epidiolex, for three rare seizure disorders.
But not much has changed for people with other forms of epilepsy like Taylor who want advice from their doctors about CBD. Joseph Sirven, a Florida neurologist who specializes in epilepsy, said all of his patients now ask about it. Despite the buzz around it, he and other physicians said they are reluctant to advise patients on over-the-counter CBD because they do not know what is in the bottles.
The FDA does little to regulate CBD, so trade groups admit that the marketplace includes potentially harmful products and that quality varies widely. They say pending bipartisan federal legislation would protect those who use CBD. But some consumer advocacy groups say the bills would have the opposite effect. [Read More @ The Washington Post]
The post Epilepsy patients navigate a murky, unregulated CBD market appeared first on Cannabis Business Executive – Cannabis and Marijuana industry news.
